A model to quantify the influence of treatment patterns and optimize outcomes in nAMDArticle Published on 2022-02-182023-06-12 Journal: Scientific Reports [Category] MERS, [키워드] Diseases Eye diseases Health care macular degeneration Medical research Outcomes research [DOI] 10.1038/s41598-022-06362-w PMC 바로가기 [Article Type] Article
Impact of cessation of regular cataract surgery during the COVID pandemic on the rates of posterior capsular rupture and post-operative cystoid macular oedemaArticle Published on 2022-02-032023-06-13 Journal: Eye (London, England) [Category] MERS, [키워드] Health services Outcomes research [DOI] 10.1038/s41433-022-01958-y PMC 바로가기 [Article Type] Article
Impacts of rapid mass vaccination against SARS-CoV2 in an early variant of concern hotspot우려 핫스팟의 초기 변종에서 SARS-CoV2에 대한 신속한 대량 백신 접종의 영향Observational Study Published on 2022-02-012022-09-10 Journal: Nature Communications [Category] COVID19(2023년), MERS, SARS, 변종, 임상, [키워드] Beta Beta variant BNT162b2 Border caused conducted control group District dose effective Epidemiology Europe excluded hospital hospitalisations hotspot ICU admissions Impact infections inoculated mass mass vaccination of BNT162b2 outbreak outcome Outcomes research Pfizer/BioNTech Population reduced infection reduced infections SARS-CoV-2 SARS-CoV2 significant decrease Spread Statistical methods the District vaccinate vaccination Vaccines variant variants variants of concern [DOI] 10.1038/s41467-022-28233-8 PMC 바로가기 [Article Type] Observational Study
Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico멕시코 최초의 유행병 이후 전국적으로 대표되는 SARS-CoV-2 항체 유병률 추정치Article Published on 2022-02-012022-09-12 Journal: Nature Communications [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95%CI age Asymptomatic Blood Blood samples COVID-19 case COVID-19 cases demographic characteristics disease severity epidemic wave Epidemiology estimate First wave group Infection Infectious diseases lockdown maximum measure Measures National Older Outcomes research Prevalence reached SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 seroprevalence Sensitivity and specificity seropositive Seroprevalence social distancing socioeconomic status the immunoassay vaccination Variation virus [DOI] 10.1038/s41467-022-28232-9 PMC 바로가기 [Article Type] Article
Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong KongArticle Published on 2022-01-202022-10-04 Journal: Nature Communications [Category] 치료법, [키워드] Adverse adverse event adverse events association chronic conditions condition CoronaVac COVID-19 vaccination database defined develop Electronic health record Epidemiology event Evidence examined first dose group groups healthcare Hong Kong increased risk individual individuals lower risk Modification Multimorbidity Outcomes research Patient public health Research Result resulting retrospective cohort risk SARS-CoV-2 specific disease vaccination Vaccine Vaccines World Health Organization [DOI] 10.1038/s41467-022-28068-3 PMC 바로가기 [Article Type] Article
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19중증 COVID-19 환자의 회복기 혈장 치료를 위한 2상 단일 센터 공개 라벨 무작위 대조 시험Clinical Trial Published on 2022-01-192022-09-12 Journal: Nature Communications [Category] SARS, 임상, 진단, 치료기술, 치료법, [키워드] 95% confidence interval adverse effect Adverse reaction all-cause mortality ARDS benefit characterized clinical clinical benefit clinical trial clinical trials Controlled trial convalescent plasma Convalescent plasma therapy COVID-19 disease cytokine Cytokines enrolment Evidence FiO2 General Hospital hazard hyper-inflammation immunization immunological inclusion criteria India Infectious disease Infectious diseases Intervention Kolkata log-rank log-rank test Mantel-Haenszel mechanical ventilation Mild Mild ARDS moderate moderate ARDS Mortality neutralizing antibody not affect not significantly different on mechanical ventilation open label outcome Outcomes research p value PaO2 paO2/fiO2 passive immunization Patient patients patients hospitalized PCR Phase 2 plasma plasma therapy prespecified outcomes Primary outcome Primary outcomes proteome randomised randomised controlled trial Randomized Ratio recruited Registered registry reported response to therapy secondary outcome Secondary outcomes severe COVID-19 severe COVID-19 disease severe COVID-19 patient severe COVID-19 patients single center Standard of care systemic hyper-inflammation the systemic hyper-inflammation therapy treat Treatment treatment arm Trial viral infection Viral RNA was done [DOI] 10.1038/s41467-022-28064-7 PMC 바로가기 [Article Type] Clinical Trial
The incidence of COVID-19 infection following emergency use authorization of BBIBP-CORV inactivated vaccine in frontline workers in the United Arab Emirates응급 사용 후 Covid-19 감염의 발생률은 아랍 에미리트의 최전선 근로자에서 BBIBP-CORV 불활성 백신의 승인Article Published on 2022-01-112022-09-10 Journal: Scientific Reports [Category] SARS, 임상, 진단, 치료기술, [키워드] 95% CI BBIBP-CorV clinical trial conducted COVID-19 COVID-19 infection COVID-19 infections dose Emergency use authorization Epidemiology EUA first dose inactivated Inactivated vaccine incidence of COVID-19 incidence rate individual Infection inoculation Medical research Outcomes research PCR positive phase Phase III clinical trials prospective cohort study reported risk SARS CoV second dose Serious Adverse Event Serious Adverse Events seroconversion rate severe disease suffered symptomatic symptomatic infection the vaccine United Arab Emirate vaccinated individual vaccinated individuals vaccination Vaccine [DOI] 10.1038/s41598-021-04244-1 PMC 바로가기 [Article Type] Article
Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescentsSARS-CoV-2 회복기의 장기 추적 및 예방 접종 중 스파이크 및 뉴클레오캡시드 특이적 면역의 역학Article Published on 2022-01-102022-09-10 Journal: Nature Communications [Category] 진단, 치료법, [키워드] Anti-viral immunity antibody antibody levels Antibody titers Asymptomatic BNT162b2 BNT162b2 mRNA boost circulating convalescent convalescent individual convalescent individuals correlated Decline declined delayed response Dynamics follow-up period Frequency Immunity increase in individual Infection long-lasting Long-term follow-up mild SARS-CoV-2 infection mRNA naïve vaccinees neutralizing antibody titers nucleocapsid Outcomes research responded to vaccination SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-specific T cells selective specific immunity spike strength T cell T cell response T cells vaccination viral infection virus-neutralizing antibody waning immunity [DOI] 10.1038/s41467-021-27649-y PMC 바로가기 [Article Type] Article
COVID-19 patient accounts of illness severity, treatments and lasting symptomsData Descriptor Published on 2022-01-102022-10-29 Journal: Scientific Data [Category] COVID-19, [키워드] age Anxiety complement Complete complications coping strategies COVID-19 illness COVID-19 patient dataset demographics Effects emotional employment Factor Health Homo sapien hospital illness Illness severity Impact impacts include Infection information Metadata novel Outcomes research pandemic Patient patient reported Perspective proximal public health quarantine question report reported response Sample Stress survey Symptom Symptoms technology the disease Treatment Variation viral infection [DOI] 10.1038/s41597-021-01103-6 PMC 바로가기 [Article Type] Data Descriptor
Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network단백질 상호 작용 네트워크를 기반으로 2019-NCOV 수용체 DPP4와 당뇨병 대상 간의 상호 관계Article Published on 2022-01-072022-08-31 Journal: Scientific Reports [Category] 바이오마커, [키워드] added Affect ALB Analysis analyzed antagonists ApoB carried Cluster cluster analysis coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection cross database diabete diabetes Diabetes Mellitus Dipeptidyl peptidase-4 DPP4 Drug development Epidemiology Final final analysis functional GeneCard Genome genomes glucagon glucagon signaling pathway high mortality highest human coronavirus IL-6 IL-6 antagonist IL6 inhibitor initial INS insulin Interaction involved KEGG Kyoto LEP management module Ontology Outcomes research Pathway analysis patients patients with diabete patients with diabetes Protein receptor Receptor binding reduce risk of death secretion selected Signaling significantly higher STRING target targets was obtained with COVID-19 [DOI] 10.1038/s41598-021-03912-6 PMC 바로가기 [Article Type] Article